Talis Biomedical Corporation (TLIS)

Talis Biomedical Analyst Ratings

• Total Analysts: 1
• Consensus Rating: Strong Sell
• Price Target: $5.00
• Upside: -45.05%

Ratings History

Filter results

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Mark Massaro BTIG	BTIG	Strong Sell Maintains $0.35 → $5	Strong Sell	Maintains	$0.35 → $5	-45.05%	Aug 16, 2023
Mark Massaro BTIG	BTIG	Hold → Strong Sell Downgrades $15	Hold → Strong Sell	Downgrades	$15	+64.84%	Mar 18, 2022
Derik De Bruin B of A Securities	B of A Securities	Sell Maintains $45 → $23	Sell	Maintains	$45 → $23	+147.25%	Mar 16, 2022
Derik De Bruin B of A Securities	B of A Securities	Hold → Sell Downgrades $45	Hold → Sell	Downgrades	$45	+394.51%	Jan 7, 2022
Tycho Peterson JP Morgan	JP Morgan	Hold → Sell Downgrades n/a	Hold → Sell	Downgrades	n/a	n/a	Sep 27, 2021
Steven Mah Piper Sandler	Piper Sandler	Buy → Hold Downgrades n/a	Buy → Hold	Downgrades	n/a	n/a	Aug 12, 2021
Mark Massaro BTIG	BTIG	Strong Buy Initiates n/a	Strong Buy	Initiates	n/a	n/a	Mar 9, 2021
Tycho Peterson JP Morgan	JP Morgan	Buy Initiates n/a	Buy	Initiates	n/a	n/a	Mar 9, 2021
Derik De Bruin B of A Securities	B of A Securities	Hold Initiates n/a	Hold	Initiates	n/a	n/a	Mar 9, 2021
Steven Mah Piper Sandler	Piper Sandler	Buy Initiates n/a	Buy	Initiates	n/a	n/a	Mar 9, 2021